Core Laboratories Inc
F:HJ1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Core Laboratories Inc
F:HJ1
|
US |
|
G
|
GEA Group AG
DUS:G1A
|
DE |
|
OPKO Health Inc
NASDAQ:OPK
|
US |
|
U
|
Umbrella Solar Investment SA
MAD:USI
|
ES |
|
B
|
Becton Dickinson and Co
SWB:BOX
|
US |
Wall St Price Targets
HJ1 Price Targets Summary
Core Laboratories Inc
According to Wall Street analysts, the average 1-year price target for HJ1 is 17.57 EUR with a low forecast of 12.78 EUR and a high forecast of 24.36 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HJ1's stock price target?
Price Target
17.57
EUR
According to Wall Street analysts, the average 1-year price target for HJ1 is 17.57 EUR with a low forecast of 12.78 EUR and a high forecast of 24.36 EUR.
What is the Revenue forecast for Core Laboratories Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Core Laboratories Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Operating Income has been -12%. The projected CAGR for the next 2 years is 1%.
What is the Net Income forecast for Core Laboratories Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been -14%. The projected CAGR for the next 2 years is 16%.
